Kura Oncology Inc (NASDAQ: KURA) kicked off on Monday, up 13.81% from the previous trading day, before settling in for the closing price of $9.7. Over the past 52 weeks, KURA has traded in a range of $5.41-$19.73.
Annual sales at Healthcare sector company slipped by -6.05% over the past five years. While this was happening, its average annual earnings per share was recorded -15.00%. With a float of $83.75 million, this company’s outstanding shares have now reached $86.80 million.
Kura Oncology Inc (KURA) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Kura Oncology Inc is 3.51%, while institutional ownership is 94.29%. The most recent insider transaction that took place on Sep 29 ’25, was worth 331,366. Before that another transaction happened on Sep 29 ’25, when Company’s Officer proposed sale 12,314 for $9.05, making the entire transaction worth $111,442.
Kura Oncology Inc (KURA) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.63 earnings per share (EPS), lower than consensus estimate (set at -0.61) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.81% during the next five years compared to -6.05% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Take a look at Kura Oncology Inc’s (KURA) current performance indicators. Last quarter, stock had a quick ratio of 6.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.51. Likewise, its price to free cash flow for the trailing twelve months is 7.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.26, a number that is poised to hit -0.73 in the next quarter and is forecasted to reach -2.30 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
Kura Oncology Inc (NASDAQ: KURA) saw its 5-day average volume 2.32 million, a positive change from its year-to-date volume of 1.54 million. As of the previous 9 days, the stock’s Stochastic %D was 47.29%.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 99.73%, which indicates a significant increase from 99.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.63 in the past 14 days, which was higher than the 0.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.74, while its 200-day Moving Average is $7.24. Nevertheless, the first resistance level for the watch stands at $11.46 in the near term. At $11.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $12.72. If the price goes on to break the first support level at $10.21, it is likely to go to the next support level at $9.38. Assuming the price breaks the second support level, the third support level stands at $8.95.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
The company with the Market Capitalisation of 958.24 million has total of 86,797K Shares Outstanding. Its annual sales at the moment are 53,880 K in contrast with the sum of -173,980 K annual income. Company’s last quarter sales were recorded 15,290 K and last quarter income was -66,120 K.
